language-icon Old Web
English
Sign In
Acemap > Paper > In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

2017 
In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    17
    References
    10
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.